Recursion Pharmaceuticals (RXRX) stock surged after the company significantly beat Street forecasts with its Q4 2025 results.

Recursion, a Fast Company "Most Innovative Company" and leader in the artificial intelligence for drug discovery movement, today announced it will open-source a glimpse of the massive biological ...

Want to make your Super Bowl party even more fun − and competitive? Look no further than Super Bowl squares. An exciting way to get everyone to watch the Big Game is with Super Bowl squares, a game ...

Football fan or not, the Super Bowl is an event that offers something for everyone. That includes the famous Super Bowl squares game, which requires no knowledge or research to play. You just have to ...

You chose selected. Each dot here represents a single video about selected. While you’re on the app, TikTok tracks how you interact with videos. It monitors your watch time, the videos you like, the ...

Abstract: The forgetting factor is the main control parameter of the recursive least-squares (RLS) algorithm, which is set to balance between the estimate accuracy and the tracking capability.

Years ago, no math education was complete without understanding how to compute a square root. Today, you are probably just reaching for a calculator, or if you are writing a program, you’ll probably ...

Researchers at NYU Langone Health created an artificial intelligence algorithm for routine computed tomography scans that automatically measures calcium buildup in the aortic valve and bone density, ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

There is a new sorting algorithm a deterministic O(m log2/3 n)-time algorithm for single-source shortest paths (SSSP) on directed graphs with real non-negative edge weights in the comparison-addition ...

Investors sold out of the biotech following a quarterly earnings release this morning. The company posted a deeper-than-expected net loss. It's common for clinical-stage biotech companies to post net ...